Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc added to abacavir-containing HIV therapy for endothelial recovery
NL-OMON38245Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant in human immunodeficiency virus infection (HIV), sponsored by University Medical Center Utrecht. Started Jan 2012; status: active, not recruiting.
02
Drugs
aprepitant
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON38245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38245.